Literature DB >> 2628363

Plasma elastase-alpha 1-antitrypsin, neopterin, tumor necrosis factor, and soluble interleukin-2 receptor after prolonged exercise.

B Dufaux1, U Order.   

Abstract

The effects of a 2.5-h running test on the plasma concentrations of elastase-alpha 1-antitrypsin, neopterin, tumor necrosis factor, and soluble interleukin-2 receptor were evaluated in eight healthy young male subjects. Neopterin was measured by radioimmunoassay, elastase-alpha 1-antitrypsin, tumor necrosis factor, and soluble interleukin-2 receptor by enzyme immunoassay. The post-exercise values were corrected for plasma volume changes which were calculated from hematocrit and hemoglobin values. Compared with the concentrations before exercise, elastase-alpha 1-antitrypsin values were significantly increased during the run (1 h after the start) (P less than 0.01) as well as during the first few hours after the end of the running test (P less than 0.01). A significant increase of tumor necrosis factor and neopterin was observed 1 h after the end and 1,3, and 24 h after the end of the running test, respectively, (P less than 0.01), and soluble interleukin-2 receptor concentrations were significantly elevated 1 and 2 days after exercise (P less than 0.01). The increase of elastase-alpha 1-antitrypsin, neopterin, tumor necrosis factor, and soluble interleukin-2 receptor supports the concept of a functional involvement of polymorphonuclear neutrophils and an activation of macrophages and T-lymphocytes after prolonged exercise.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2628363     DOI: 10.1055/s-2007-1024939

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  20 in total

1.  Serum concentrations of C reactive protein, alpha1 antitrypsin, and complement (C3, C4, C1 esterase inhibitor) before and during the Vuelta a Espańa.

Authors:  S J Semple; L L Smith; A J McKune; J Hoyos; B Mokgethwa; A F San Juan; A Lucia; A A Wadee
Journal:  Br J Sports Med       Date:  2006-02       Impact factor: 13.800

2.  Effects of submaximal cycling and long-term endurance training on neutrophil phagocytic activity in middle aged men.

Authors:  A K Blannin; L J Chatwin; R Cave; M Gleeson
Journal:  Br J Sports Med       Date:  1996-06       Impact factor: 13.800

3.  Exercise and the neutrophil oxidative burst: biological and experimental variability.

Authors:  D B Pyne; M S Baker; J A Smith; R D Telford; M J Weidemann
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

4.  Immune system of cold-exposed and cold-adapted humans.

Authors:  L Janský; D Pospísilová; S Honzová; B Ulicný; P Srámek; V Zeman; J Kamínková
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

5.  Delayed muscle soreness. The inflammatory response to muscle injury and its clinical implications.

Authors:  D L MacIntyre; W D Reid; D C McKenzie
Journal:  Sports Med       Date:  1995-07       Impact factor: 11.136

Review 6.  Are similar inflammatory factors involved in strenuous exercise and sepsis?

Authors:  G Camus; G Deby-Dupont; J Duchateau; C Deby; J Pincemail; M Lamy
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

7.  Effects of moderate endurance exercise and training on in vitro lymphocyte proliferation, interleukin-2 (IL-2) production, and IL-2 receptor expression.

Authors:  S G Rhind; P N Shek; S Shinkai; R J Shephard
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

Review 8.  Exercise and the immune system. Natural killer cells, interleukins and related responses.

Authors:  R J Shephard; S Rhind; P N Shek
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

Review 9.  Selected scientific aspects of marathon racing. An update on fluid replacement, immune function, psychological factors and the gender difference.

Authors:  P B Sparling; D C Nieman; P J O'Connor
Journal:  Sports Med       Date:  1993-02       Impact factor: 11.136

10.  Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans.

Authors:  K Ostrowski; T Rohde; S Asp; P Schjerling; B K Pedersen
Journal:  J Physiol       Date:  1999-02-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.